Linda Chang is a financial expert with a well-balanced financial background that enhances any business environment. Ms. Chang’s executive experience, largely as a Chief Financial Officer, encompassed organizations of all sizes. Her experience includes numerous merger & acquisition activities, preparing for a public offering, financial restructurings, implementation of control environments and relocation/consolidation of business operations. In addition to managing finance and accounting operations, she has managed information technology, administrative, contracts, human resources, and legal functions.
Ms. Chang is currently the Chief Financial Officer of Euclid Vision Group. Prior to her role at Euclid, Ms. Chang served as Chief Financial Officer and Chief Operating Office of Science and Medicine Group. She was the Chief Financial Officer and Treasurer of Osiris Therapeutics, the Senior Vice President, Chief Financial Officer of Therabron Therapeutics, the Senior Vice President, Chief Financial Officer, Treasurer and Corporate Secretary of Pharmathene and the Senior Finance Director of Human Genome Sciences, Inc.